About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Chicago | 715 Studies

Clinical Trials Breast CancerChicago

Breast Cancer Clinical Trials in Chicago

Find 715 clinical trials for breast cancer near Chicago, Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 715 trials

CompletedBreast Cancer - Navigate - Prospective CohortThe Chrysalis Initiative (TCI) has with its technology partner Eversana/Intouch developed the BC-Navigate website/application to help guide women through care delivery during…NCT06271356·Chicago, Illinois TerminatedA Study in Patients With Advanced Breast CancerA Phase 1, Open label, Dose escalation and Dose expansion study of SCO-120 in HR +ve HER2-ve advanced/ metastatic breast cancer (MBC) patients to evalaute the safety, tolerability…NCT04942054·Newport Beach, California and 5 others Active not recruitingPhase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryThis randomized phase I trial studies the side effects and best dose of endoxifen hydrochloride in treating participants who are undergoing breast surgery.NCT03317405·Los Angeles, California and 2 others

Breast Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPromoting Genetic Counseling Among African American Women With a Family History of Breast CancerIn the United States, carriers of hereditary genetic mutations have up to an 85% risk of developing breast cancer compared to 12% in the general population.NCT04378751·Chicago, Illinois and 1 other

TerminatedVaccine-Based Immunotherapy Regimen For NSCLC and TNBCPart 1of the study will evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenicity of increasing doses of a vaccine-based immunotherapy regimen (VBIR-2) for…NCT03674827·Encinitas, California and 33 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

Active not recruitingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK…NCT02568267·Phoenix, Arizona and 119 others

RecruitingTesting Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialThis phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has…NCT06500481·Phoenix, Arizona and 57 others

UnknownA Prospective Study of Breast Cancer Patients With Abnormal Strain ImagingThe Cardio-Oncology program at Northwestern offers care to cancer patients who develop cardiac toxicities from chemotherapy.NCT02993198·Chicago, Illinois

CompletedLisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabRATIONALE: Lisinopril or Coreg CR®, may help reduce side effects caused by trastuzumab.NCT01009918·Long Beach, California and 173 others

CompletedTrial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast CancerThe primary purpose of phase 1 portion of this study is to determine the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of H3B-6545 in women with locally…NCT03250676·Goodyear, Arizona and 38 others

CompletedStudy Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerThe primary objective of the study is to assess the progression-free survival (PFS) of oral veliparib in combination with TMZ or in combination with carboplatin and paclitaxel…NCT01506609·Birmingham, Alabama and 119 others

Active not recruitingIntraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving SurgeryThis phase IV trial studies the side effects of intraoperative radiation therapy and how well it works in treating patients with breast cancer undergoing breast-conserving surgery.NCT01570998·Berkeley, California and 24 others

CompletedPaclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryThis randomized phase III trial studies paclitaxel and trastuzumab with or without lapatinib to see how well they work in treating patients with stage II or stage III breast…NCT00770809·Tucson, Arizona and 317 others

CompletedPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients…NCT00861705·Jonesboro, Arkansas and 447 others

CompletedTucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast CancerThis is a multicenter run-in phase Ib / roll-over phase II study of triple targeted drug combination (HER2-targeted small molecule inhibitor tucatinib, CDK4/6 inhibitor…NCT03054363·Tucson, Arizona and 5 others

CompletedA Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with breast cancer after having…NCT00063102·Miami, Florida and 7 others

Active not recruitingOlaparib In Metastatic Breast CancerThis research study is for patients with metastatic breast cancer. * Metastatic means that the cancer has spread beyond the breast.NCT03344965·Birmingham, Alabama and 19 others

CompletedTrial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer SubjectsThe purpose of this study is to compare active immunotherapy (OPT-822/OPT-821) with PBS in combination with low dose cyclophosphamide, in post-treated metastatic breast cancer…NCT01516307·Birmingham, Alabama and 42 others

CompletedNeratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast CancerThis phase II study will test cancer to see if it has a HER2 mutation and, if so, see how HER2 mutated cancer responds to treatment with neratinib.NCT01670877·Birmingham, Alabama and 16 others

Page 1 of 36Next

Other Conditions in Chicago

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma